Cargando…

ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma

BACKGROUND: Glutamine is an abundant and versatile nutrient in cancer cells. Head and neck squamous cell carcinoma (HNSCC) was reported to be dependent on mainly glucose, not glutamine, for producing the energy required for survival and proliferation. METHODS: The roles of ASCT2 (SLC1A5) and associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ze, Liu, Ruoyan, Shuai, Yanjie, Huang, Yuting, Jin, Rui, Wang, Xudong, Luo, Jingtao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964701/ https://www.ncbi.nlm.nih.gov/pubmed/31819178 http://dx.doi.org/10.1038/s41416-019-0637-9

Ejemplares similares

Integrating Clinical and Genetic Analysis of Perineural Invasion in Head and Neck Squamous Cell Carcinoma
por: Zhang, Ze, et al.
Publicado: (2019)

ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma
por: Marshall, A D, et al.
Publicado: (2017)

BCAR3 promotes head and neck cancer growth and is associated with poor prognosis
por: Zhang, Ze, et al.
Publicado: (2021)

ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer
por: van Geldermalsen, M, et al.
Publicado: (2016)

Structural characterisation reveals insights into substrate recognition by the glutamine transporter ASCT2/SLC1A5
por: Scopelliti, Amanda J, et al.
Publicado: (2018)

Targeting ASCT2‐mediated glutamine uptake blocks prostate cancer growth and tumour development
por: Wang, Qian, et al.
Publicado: (2015)

Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation
por: Yu, Xiaodi, et al.
Publicado: (2019)

Targeting of glutamine transporter ASCT2 and glutamine synthetase suppresses gastric cancer cell growth
por: Ye, Jianxin, et al.
Publicado: (2018)

The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)
por: Cormerais, Yann, et al.
Publicado: (2018)

Homology Modeling Informs Ligand Discovery for the Glutamine Transporter ASCT2
por: Garibsingh, Rachel-Ann A., et al.
Publicado: (2018)

ASCT2 overexpression is associated with poor survival of OSCC patients and ASCT2 knockdown inhibited growth of glutamine‐addicted OSCC cells
por: Luo, Yijun, et al.
Publicado: (2020)

CAV2 promotes the invasion and metastasis of head and neck squamous cell carcinomas by regulating S100 proteins
por: Wang, Yafei, et al.
Publicado: (2022)

SEMA3C Promotes Cervical Cancer Growth and Is Associated With Poor Prognosis
por: Liu, Ruoyan, et al.
Publicado: (2019)

Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism
por: Dong, J, et al.
Publicado: (2017)

Pharmacological Blockade of ASCT2-dependent Glutamine Transport Leads To Anti-tumor Efficacy in Preclinical Models
por: Schulte, Michael L., et al.
Publicado: (2018)

Targeting ASCT2-mediated glutamine metabolism inhibits proliferation and promotes apoptosis of pancreatic cancer cells
por: Wang, Wenbin, et al.
Publicado: (2022)

D-Serine Is a Substrate for Neutral Amino Acid Transporters ASCT1/SLC1A4 and ASCT2/SLC1A5, and Is Transported by Both Subtypes in Rat Hippocampal Astrocyte Cultures
por: Foster, Alan C., et al.
Publicado: (2016)

Cys Site-Directed Mutagenesis of the Human SLC1A5 (ASCT2) Transporter: Structure/Function Relationships and Crucial Role of Cys467 for Redox Sensing and Glutamine Transport
por: Scalise, Mariafrancesca, et al.
Publicado: (2018)

Clinical Role of ASCT2 (SLC1A5) in KRAS-Mutated Colorectal Cancer
por: Toda, Kosuke, et al.
Publicado: (2017)

NDRG2 ablation reprograms metastatic cancer cells towards glutamine dependence via the induction of ASCT2
por: Ding, Mingchao, et al.
Publicado: (2020)

Immune-related lncRNA classification of head and neck squamous cell carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2022)

A Novel ASCT2 Inhibitor, C118P, Blocks Glutamine Transport and Exhibits Antitumour Efficacy in Breast Cancer
por: Lyu, Xiao-Dan, et al.
Publicado: (2023)

Comprehensive Analysis of the PRDXs Family in Head and Neck Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2022)

Interaction of Cholesterol With the Human SLC1A5 (ASCT2): Insights Into Structure/Function Relationships
por: Scalise, Mariafrancesca, et al.
Publicado: (2019)

Functional and Kinetic Comparison of Alanine Cysteine Serine Transporters ASCT1 and ASCT2
por: Wang, Jiali, et al.
Publicado: (2022)

SPDEF suppresses head and neck squamous cell carcinoma progression by transcriptionally activating NR4A1
por: Wang, Yanting, et al.
Publicado: (2021)

Integrative Analysis of TP53INP2 in Head and Neck Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2021)

Inhibition of glucose metabolism prevents glycosylation of the glutamine transporter ASCT2 and promotes compensatory LAT1 upregulation in leukemia cells
por: Polet, Florence, et al.
Publicado: (2016)

Ag120-Mediated Inhibition of ASCT2-Dependent Glutamine Transport has an Anti-Tumor Effect on Colorectal Cancer Cells
por: Yu, Wei, et al.
Publicado: (2022)

Management of Chemoradiation-Induced Mucositis in Head and Neck Cancers With Oral Glutamine
por: Pattanayak, Lucy, et al.
Publicado: (2016)

Low temperature bacterial expression of the neutral amino acid transporters SLC1A5 (ASCT2), and SLC6A19 (B0AT1)
por: Galluccio, Michele, et al.
Publicado: (2020)

SLC13A4 Might Serve as a Prognostic Biomarker and be Correlated with Immune Infiltration into Head and Neck Squamous Cell Carcinoma
por: Yang, Meng-Ling, et al.
Publicado: (2021)

Targeting glutamine uptake in AML
por: Jacque, Nathalie, et al.
Publicado: (2014)

Uptake and fate of surface modified silica nanoparticles in head and neck squamous cell carcinoma
por: Besic Gyenge, Emina, et al.
Publicado: (2011)

Comparison of FDG and FMISO uptakes and distributions in head and neck squamous cell cancer tumors
por: Nehmeh, Sadek A., et al.
Publicado: (2021)

The Human SLC1A5 (ASCT2) Amino Acid Transporter: From Function to Structure and Role in Cell Biology
por: Scalise, Mariafrancesca, et al.
Publicado: (2018)

ASCT2 (SLC1A5)-Deficient Mice Have Normal B-Cell Development, Proliferation, and Antibody Production
por: Masle-Farquhar, Etienne, et al.
Publicado: (2017)

Comprehensive Analysis of the Role of SLC2A3 on Prognosis and Immune Infiltration in Head and Neck Squamous Cell Carcinoma
por: Chu, Manru, et al.
Publicado: (2022)

Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening
por: Colas, Claire, et al.
Publicado: (2015)

Disruption of Amino Acid Homeostasis by Novel ASCT2 Inhibitors Involves Multiple Targets
por: Bröer, Angelika, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uq2ijbiek6eihnj6frq4khee1s